Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Infectious Diseases

• Publication date

  2007-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/512245PMID 17330798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Further studies on cytomegalovirus mononucleosis in previously healthy individuals.

  2009cited by this paper
• Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases

  2006cited by this paper
• Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers.

  2006cited by this paper
• Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants.

  2006cited by this paper
• Monitoring of Human Cytomegalovirus‐Specific CD4+ and CD8+ T‐Cell Immunity in Patients Receiving Solid Organ Transplantation

  2006cited by this paper
• Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions.

  2005cited by this paper
• Flow-Cytometric Detection of Vaccinia-Induced Memory Effector CD4+, CD8+, and γδTCR+ T Cells Capable of Antigen-Specific Expansion and Effector Functions

  2005cited by this paper
• Simultaneous quantification of human cytomegalovirus (HCMV)‐specific CD4+ and CD8+ T cells by a novel method using monocyte‐derived HCMV‐infected immature dendritic cells

  2005cited by this paper
• Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells.

  2005cited by this paper
• In vitro human memory CD8 T cell expansion in response to cytomegalovirus requires CD4+ T cell help.

  2004influential reference
• Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.

  2003cited by this paper
• A sensitive method for detecting proliferation of rare autoantigen-specific human T cells.

  2003cited by this paper
• Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections.

  2002cited by this paper
• Declining Levels of Rescued Lymphoproliferative Response to Human Cytomegalovirus (HCMV) in AIDS Patients With or Without HCMV Disease Following Long‐Term HAART

  2001cited by this paper
• Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution.

  2000cited by this paper
• Asymptomatic primary cytomegalovirus infection: virologic and immunologic features.

  1999cited by this paper
• Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns.

  1999cited by this paper
• Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy.

  1998cited by this paper
• Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction

  1998cited by this paper
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

  1994cited by this paper
• Lymphocyte responses and virus excretion as risk factors for intrauterine infection with cytomegalovirus

  1993cited by this paper
• Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

  1992cited by this paper
• The outcome of congenital cytomegalovirus infection in relation to maternal antibody status

  1992cited by this paper
• Congenital cytomegalovirus infection and maternal antibody status.

  1992cited by this paper
• Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.

  1991cited by this paper
• Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans.

  1991cited by this paper
• Antibody response to virus-encoded proteins after cytomegalovirus mononucleosis.

  1987cited by this paper
• Primary Cytomegalovirus Infection in Pregnancy: Incidence, Transmission to Fetus, and Clinical Outcome

  1987cited by this paper
• An early marker of fetal infection after primary cytomegalo‐virus infection in pregnancy

  1987cited by this paper
• An early marker of fetal infection after primary cytomegalovirus infection in pregnancy.

  1986cited by this paper
• Risk factors for cytomegalovirus infection after human marrow transplantation.

  1986cited by this paper
• Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome.

  1986cited by this paper
• Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection.

  1982cited by this paper
• Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy

  1981cited by this paper
• Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant.

  1980cited by this paper
• Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers.

  1979cited by this paper
• Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis.

  1965cited by this paper

• A vaccine against cytomegalovirus: how close are we?

  2025cites this paper
• The immune response to human cytomegalovirus: impact of age, co-morbidities and the significance of anti-viral activity assessment

  2025cites this paper
• The urgent search for predictive biomarkers in the emerging era of universal congenital cytomegalovirus screening.

  2025cites this paper
• Safety and Immunogenicity of a Messenger RNA–Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1 Randomized Clinical Trial

  2024cites this paper
• Tissue Resident CD8+T-cells as mediators of protective immunity in breastmilk transmission of HCMV.

  2024cites this paper
• T-Cell Immune Responses in Newborns and Long-Term Sequelae in Congenital Cytomegalovirus Infection (CYTRIC Study).

  2024cites this paper
• Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine

  2024cites this paper
• Novel monoclonal antibody-based therapies: implications for the treatment and prevention of HCMV disease.

  2023cites this paper
• The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmission

  2023cites this paper
• Primary, Secondary, and Tertiary Prevention of Congenital Cytomegalovirus Infection

  2023cites this paper
• Cell-mediated and humoral immune responses to human cytomegalovirus in pregnant women with vertically transmitted infection following primary infection: A case report.

  2023cites this paper
• Can We Prevent Congenital Infection By Cytomegalovirus?

  2023cites this paper
• Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy

  2023cites this paper
• Interferon-gamma FlowSpot assay for the measurement of the T-cell response to cytomegalovirus

  2023cites this paper
• Lessons from Acquired Natural Immunity and Clinical Trials to Inform Next-Generation Human Cytomegalovirus Vaccine Development.

  2022cites this paper
• Neutralizing Antibodies to Human Cytomegalovirus Recombinant Proteins Reduce Infection in an Ex Vivo Model of Developing Human Placentas

  2022cites this paper
• Risk assessment of human cytomegalovirus infection in solid organ transplantation: Insight into CD4+ T cell subsets

  2022cites this paper
• Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals?

  2022cites this paper
• Human cytomegalovirus (HCMV) long-term shedding and HCMV-specific immune response in pregnant women with primary HCMV infection

  2022cites this paper
• Presentation and recognition of placental, fetal, and pathogen-derived antigens in human pregnancy

  2021cites this paper
• Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.

  2021cites this paper
• Congenital Human Cytomegalovirus Infection: A Narrative Review of Maternal Immune Response and Diagnosis in View of the Development of a Vaccine and Prevention of Primary and Non-Primary Infections in Pregnancy

  2021cites this paper
• A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial

  2021cites this paper
• Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice

  2021cites this paper
• A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial

  2021cites this paper
• Microcephaly: Zika and other congenital infections

  2021cites this paper
• CMV-Specific Cell-Mediated Immunity in Immunocompetent Adults with Primary CMV Infection: A Case Series and Review of the Literature

  2021cites this paper
• Maternal Immunization: Nature Meets Nurture

  2020cites this paper
• Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization

  2020cites this paper
• Requirements for guinea pig cytomegalovirus tropism and antibody neutralization on placental amniotic sac cells.

  2020cites this paper
• Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.

  2020influential citation
• Human Cytomegalovirus Congenital (cCMV) Infection Following Primary and Nonprimary Maternal Infection: Perspectives of Prevention through Vaccine Development

  2020cites this paper
• The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People

  2020cites this paper
• Slow cytomegalovirus‐specific CD4+ and CD8+ T‐cell differentiation: 10‐year follow‐up of primary infection in a small number of immunocompetent hosts

  2020cites this paper
• Viral-Immune Cell Interactions at the Maternal-Fetal Interface in Human Pregnancy

  2020cites this paper
• Functional Evaluation and Genetic Evolution of Human T-cell Responses after Vaccination with a Conditionally Replication-Defective Cytomegalovirus Vaccine.

  2020cites this paper
• Estado actual de las vacunas frente a la infección congénita por citomegalovirus: la paradoja de la inmunidad previa

  2020cites this paper
• Role of Inflammation in Virus Pathogenesis during Pregnancy

  2020cites this paper
• Current status of vaccines against congenital cytomegalovirus infection: The paradox of previous immunity

  2020cites this paper
• Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects.

  2019cites this paper
• Inclusion of the Viral Pentamer Complex in a Vaccine Design Greatly Improves Protection against Congenital Cytomegalovirus in the Guinea Pig Model

  2019cites this paper
• A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection

  2019cites this paper
• Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas

  2019cites this paper
• Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine.

  2019cites this paper
• HCMV glycoprotein B nucleoside-modified mRNA vaccine elicits antibody responses with greater durability and breadth than MF59-adjuvanted gB protein immunization

  2019cites this paper
• Survey of cellular immune responses to human cytomegalovirus infection in the microenvironment of the uterine–placental interface

  2019cites this paper
• 16 – Cytomegalovirus Vaccines

  2018cites this paper
• Impact of congenital cytomegalovirus infection on transcriptomes from archived dried blood spots in relation to long-term clinical outcome

  2018cites this paper
• Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients.

  2018cites this paper
• Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice

  2018cites this paper
• Maternal Immunity and the Natural History of Congenital Human Cytomegalovirus Infection

  2018cites this paper
• A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection

  2018cites this paper
• University Assessment of the T-SPOT.CMV interferon- release assay in renal transplant recipients: A single center cohort study

  2018cites this paper
• Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections

  2018cites this paper
• University Assessment of the T-SPOT.CMV interferon- release assay in renal transplant recipients: A single center cohort study

  2018cites this paper
• Assessment of the T-SPOT.CMV interferon-γ release assay in renal transplant recipients: A single center cohort study

  2018cites this paper
• Human cytomegalovirus (HCMV)‐specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid‐organ transplant recipients

  2018cites this paper
• Defining the Role of Antibodies in Protection Against Cytomegalovirus Acquisition and Congenital Disease for Rational Vaccine Design

  2018cites this paper
• Vaccine Development for Cytomegalovirus.

  2018cites this paper
• Human Cytomegalovirus–Specific Memory CD4+ T-Cell Response and Its Correlation With Virus Transmission to the Fetus in Pregnant Women With Primary Infection

  2017cites this paper
• Maternal immune correlates of protection against placental transmission of cytomegalovirus.

  2017cites this paper
• Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection

  2017cites this paper
• Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections.

  2017cites this paper
• Congenital Cytomegalovirus Infection: Improved Understanding of Maternal Immune Responses That Reduce the Risk of Transplacental Transmission.

  2017cites this paper
• The pathogenesis of microcephaly resulting from congenital infections: why is my baby’s head so small?

  2017cites this paper
• Phenotype and specificity of T cells in primary human cytomegalovirus infection during pregnancy: IL-7Rpos long-term memory phenotype is associated with protection from vertical transmission

  2017cites this paper
• Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy

  2017cites this paper
• A replication-defective human cytomegalovirus vaccine for prevention of congenital infection

  2016cites this paper
• Diagnostic moléculaire du Cytomégalovirus (CMV), de l’herpès virus humain de type 6 (HHV6) et d’Epstein-Barr virus (EBV) par PCR en temps réel chez les femmes enceintes VIH séropositives et séronégatives à Ouagadougou, Burkina Faso

  2016cites this paper
• Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli.

  2016cites this paper
• The March towards a Vaccine for Congenital CMV: Rationale and Models

  2016cites this paper
• Comparative magnitude and kinetics of human cytomegalovirus‐specific CD4+ and CD8+ T‐cell responses in pregnant women with primary versus remote infection and in transmitting versus non‐transmitting mothers: Its utility for dating primary infection in pregnancy

  2016cites this paper
• Low Interferon Relative-Response to Cytomegalovirus Is Associated with Low Likelihood of Intrauterine Transmission of the Virus

  2016cites this paper
• Cytomegalovirus vaccines under clinical development

  2016cites this paper
• Current Status of Cytomegalovirus Vaccines: 2016

  2016cites this paper
• [Molecular tests in diagnosis of Cytomegalovirus (CMV), human herpesvirus 6 (HHV-6) and Epstein-Barr virus (EBV) using real-time PCR in HIV positive and HIV-negative pregnant women in Ouagadougou, Burkina Faso].

  2016cites this paper
• Prospects of a vaccine for the prevention of congenital cytomegalovirus disease

  2016cites this paper
• Functional Exhaustion Limits CD4+ and CD8+ T-Cell Responses to Congenital Cytomegalovirus Infection.

  2015cites this paper
• The Cellular Localization of Human Cytomegalovirus Glycoprotein Expression Greatly Influences the Frequency and Functional Phenotype of Specific CD4+ T Cell Responses

  2015cites this paper
• Strong Cell-Mediated Immune Response to Human Cytomegalovirus Is Associated With Increased Risk of Fetal Infection in Primarily Infected Pregnant Women.

  2015cites this paper
• Vaccination for cytomegalovirus: when, where and how

  2015cites this paper
• Immunity to Cytomegalovirus in Early Life

  2014cites this paper
• Conséquences de l'infection à cytomégalovirus sur le placenta humain

  2014cites this paper
• Infection of Fibroblasts and Epithelial Cells Neutralizing Antibodies That Prevent Cellular Immune Responses and Broad Towne-Derived Dense Bodies Induce Cytomegalovirus Vaccine Strain

  2014cites this paper
• Alterations in TLRs as new molecular markers of congenital infections with Human cytomegalovirus?

  2014cites this paper
• Role of human cytomegalovirus (HCMV)-specific antibody in HCMV-infected pregnant women.

  2014cites this paper
• Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease.

  2014cites this paper
• The immunological underpinnings of vaccinations to prevent cytomegalovirus disease

  2014cites this paper
• Recent approaches and strategies in the generation of antihuman cytomegalovirus vaccines.

  2014cites this paper
• Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease.

  2014cites this paper
• Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection

  2013cites this paper
• Complex correlates of protection after vaccination.

  2013cites this paper
• Analysis of CMV-specific T cell responses and CMV-associated changes in the ageing human immune system

  2013cites this paper
• CD8+ Effector T Cells at the Fetal–Maternal Interface, Balancing Fetal Tolerance and Antiviral Immunity

  2013cites this paper
• 43 – Cytomegalovirus vaccines

  2013cites this paper
• Cytomegalovirus Vaccine Strain Towne-Derived Dense Bodies Induce Broad Cellular Immune Responses and Neutralizing Antibodies That Prevent Infection of Fibroblasts and Epithelial Cells

  2013cites this paper
• Fetal Human Cytomegalovirus Transmission Correlates with Delayed Maternal Antibodies to gH/gL/pUL128-130-131 Complex during Primary Infection

  2013cites this paper
• The “Silent” Global Burden of Congenital Cytomegalovirus

  2013cites this paper
• Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine

  2013cites this paper
• Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK‐cell subset distribution in children

  2012cites this paper